Citez comme : (2023, janvier) A randomized clinical trial to test efficacy of chamomile and saffron for neuroprotective and anti-inflammatory responses in depressive patients. https://geertdevuyst.fr/publication/2022-ahmad-a-randomized-clinical-trial-to-test-efficacy-of-chamomile-and-saffron-for-neuroprotective-and-anti-inflammatory-responses-in-depressive-patients/
A randomized clinical trial to test efficacy of chamomile and saffron for neuroprotective and anti-inflammatory responses in depressive patients
Article anglais Formé(e)
TitreA randomized clinical trial to test efficacy of chamomile and saffron for neuroprotective and anti-inflammatory responses in depressive patientsAuteur(s)Ahmad, S., Azhar, A., Tikmani, P., Rafique, H., Khan, A., Mesiya, H., & Saeed, H.PublicationHeliyonVolume8Édition10Année de publication2022Pagese10774DOIhttps://doi.org/10.1016/j.hel ... EditeurElsevier BVCitez commeAhmad, S., Azhar, A., Tikmani, P., Rafique, H., Khan, A., Mesiya, H., & Saeed, H. (2022). A randomized clinical trial to test efficacy of chamomile and saffron for neuroprotective and anti‑inflammatory responses in depressive patients. Heliyon, 8(10), e10774. https://doi.org/10.1016/j.heliyon.2022.e10774